Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

DW Ellison, J Dalton, M Kocak, SL Nicholson… - Acta …, 2011 - Springer
Medulloblastoma is heterogeneous, being characterized by molecular subgroups that
demonstrate distinct gene expression profiles. Activation of the WNT or SHH signaling …
被引用次数：643 相关文章

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.

DW Ellison, J Dalton, M Kocak, SL Nicholson… - Acta …, 2011 - europepmc.org
Medulloblastoma is heterogeneous, being characterized by molecular subgroups that
demonstrate distinct gene expression profiles. Activation of the WNT or SHH signaling …

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.

D Ellison, J Dalton, M Kocak… - Acta …, 2011 - search.ebscohost.com
Medulloblastoma is heterogeneous, being characterized by molecular subgroups that
demonstrate distinct gene expression profiles. Activation of the WNT or SHH signaling …

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

DW Ellison, J Dalton, M Kocak, SL Nicholson… - Acta …, 2011 - eprints.ncl.ac.uk
Medulloblastoma is heterogeneous, being characterized by molecular subgroups that
demonstrate distinct gene expression profiles. Activation of the WNT or SHH signaling …
[PDF] researchgate.net

[PDF][PDF] Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

DW Ellison, J Dalton, M Kocak, SL Nicholson, C Fraga… - 2011 - researchgate.net
Medulloblastoma is heterogeneous, being characterized by molecular subgroups that
demonstrate distinct gene expression profiles. Activation of the WNT or SHH signaling …

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

DW Ellison, J Dalton, M Kocak… - Acta …, 2011 - pubmed.ncbi.nlm.nih.gov
Medulloblastoma is heterogeneous, being characterized by molecular subgroups that
demonstrate distinct gene expression profiles. Activation of the WNT or SHH signaling …
[HTML] nih.gov

[HTML][HTML] Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

DW Ellison, J Dalton, M Kocak, SL Nicholson… - Acta …, 2011 - ncbi.nlm.nih.gov
Medulloblastoma is heterogeneous, being characterized by molecular subgroups that
demonstrate distinct gene expression profiles. Activation of the WNT or SHH signaling …

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

DW Ellison, J Dalton, M Kocak, SL Nicholson… - Acta …, 2011 - hero.epa.gov
Medulloblastoma is heterogeneous, being characterized by molecular subgroups that
demonstrate distinct gene expression profiles. Activation of the WNT or SHH signaling …
[PDF] psu.edu

[PDF][PDF] Gilbertson Medulloblastoma: RJ. Clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

D Ellison, M Kocak, G Neale, AM Kenney - 2011 - Citeseer
Medulloblastoma is heterogeneous, being characterized by molecular subgroups that
demonstrate distinct gene expression profiles. Activation of the WNT or SHH signaling …

Medulloblastoma: Clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

DW Ellison, J Dalton, M Kocak… - Acta …, 2011 - scholars.northwestern.edu
Medulloblastoma is heterogeneous, being characterized by molecular subgroups that
demonstrate distinct gene expression profiles. Activation of the WNT or SHH signaling …